NICE - blood pressure control in acute stroke
Last edited 06/2019
NICE state (1):
Blood pressure control for people with acute ischaemic stroke
-
anti-hypertensive treatment in people with acute stroke is recommended only if there is a hypertensive emergency with one or more of the following serious concomitant medical issues:
- hypertensive encephalopathy
- hypertensive nephropathy
- hypertensive cardiac failure/myocardial infarction
- aortic dissection
- pre-eclampsia/eclampsia
- blood pressure reduction to 185/110 mmHg or lower should be considered in people who are candidates for thrombolysis
Blood pressure control for people with acute intracerebral haemorrhage
- rapid blood pressure lowering treatment should be offered to people with
acute intracerebral haemorrhage who do not have any of the exclusions listed*
and who:
- present within 6 hours of symptom onset and
- have a systolic blood pressure between 150 and 220 mmHg
- aim for a systolic blood pressure target of 130 to 140 mmHg within 1 hour of starting treatment and maintain this blood pressure for at least 7 days
- consider rapid blood pressure lowering for people with acute intracerebral
haemorrhage who do not have any of the exclusions listed * and who:
- present beyond 6 hours of symptom onset or
- have a systolic blood pressure greater than 220mmHg
- aim for a systolic blood pressure target of 130 to 140 mmHg within 1 hour of starting treatment and maintain this blood pressure for at least 7 days
* do not offer rapid blood pressure lowering to people who:
- have an underlying structural cause (for example, tumour, arteriovenous malformation or aneurysm)
- have a score on the Glasgow Coma Scale of below 6
- are going to have early neurosurgery to evacuate the haematoma
- have a massive haematoma with a poor expected prognosis
Notes:
- there is no definitive evidence as to whether antihypertensive drugs should
be started immediately after an ischaemic stroke or if current medication
should be continued in the acute post-ictal phase
- in a study investigating the treatment of hypertension post stroke (patients
over 18 years admitted to hospital with a clinical diagnosis of suspected
stroke and symptom onset < 36 hours and hypertension, defined as systolic
BP (SBP) < 160 mmHg) (2)
- oral and sublingual lisinopril and oral and intravenous labetalol
were effective BP-lowering agents in acute cerebral infarction and
haemorrhage and did not increase the likelihood of early neurological
deterioration
- study was not sufficiently powered to detect a difference in disability or death at 2 weeks
- oral and sublingual lisinopril and oral and intravenous labetalol
were effective BP-lowering agents in acute cerebral infarction and
haemorrhage and did not increase the likelihood of early neurological
deterioration
- in a study investigating the treatment of hypertension post stroke (patients
over 18 years admitted to hospital with a clinical diagnosis of suspected
stroke and symptom onset < 36 hours and hypertension, defined as systolic
BP (SBP) < 160 mmHg) (2)
Reference:
PROGRESS (perindopril protection against recurrent stroke study)